Genetesis: Genetesis enrols first subject for MICRO2 trial

Genetesis has enrolled the first patient marking the start of its Magnetocardiography as a Noninvasive Diagnostic Strategy for Suspected Myocardial Ischemia with the Absence of Obstructive Coronary Artery Disease (MICRO2) trial at Ascension St. John Hospital in Michigan, US. The post Genetesis enrols first subject for MICRO2 trial appeared first on Medical Device Network.